SCHEMBL3395811

SCHEMBL3395811

COc1cc(Cn2cnc3c(OC)ncnc32)cc(OC)c1OC

nearest known ligand 0.66

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 6/20 0.57
▸ HSP90AB1 P08238 6/20 0.57
▸ HPGD P15428 1/20 0.52
▸ DAPK1 P53355 1/20 0.49
▸ FLT4 P35916 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ KDM4E B2RXH2 2/20 0.43
▸ YTHDC1 Q96MU7 1/20 0.42
▸ MEN1 O00255 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MITF O75030 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TAAR1 Q96RJ0 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3395858 0.86 HSP90AA1 (0.62) HSP90AA1HSP90AB1HPGDLMNASMN1; SMN2
SCHEMBL3396153 0.86 HSP90AA1 (0.69) HSP90AA1HSP90AB1HPGDKDM4EYTHDC1
SCHEMBL3396083 0.83 HSP90AA1 (0.71) HSP90AA1HSP90AB1HPGDDAPK1FLT4
SCHEMBL3393558 0.81 HSP90AB1 (0.77) HSP90AA1HSP90AB1
9-Benzyl-6-Methoxy-9H-Purine SCHEMBL28939425 0.80 HPGD (0.77) HPGDDAPK1FLT4KDRKDM4E
SCHEMBL5458555 0.77 ADORA2A (0.52) HSP90AA1HSP90AB1
SCHEMBL28939424 0.77 HPGD (0.59) HPGDDAPK1FLT4KDRMEN1
SCHEMBL3393884 0.76 HSP90AA1 (0.48) HSP90AA1HSP90AB1HPGDDAPK1FLT4
SCHEMBL17364335 0.75 ADORA2A (0.60) HPGDDAPK1FLT4KDRMEN1
SCHEMBL22533420 0.74 HPGD (0.56) HPGDDAPK1FLT4KDRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2145888-A1 Deazapurine derivatives as HSP90-Inhibitors Conforma Therapeutics Corporation (US) 2010-01-20 — — EP disclosed
EP-1670802-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS Conforma Therapeutic Corporation (US) 2006-06-21 — — EP disclosed
WO-2005028434-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2005-03-31 — — WO disclosed
Send feedback